BYSI logo

BeyondSpring Inc. Ordinary Shares

BYSI

BYSI: BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China.

more

Show BYSI Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of BYSI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by BYSI's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $20,000 Jul 20, 2023 Issue: Health Issues
  • $20,000 Apr 20, 2023 Issue: Health Issues
  • $20,000 Jan 20, 2023 Issue: Health Issues
  • $20,000 Oct 28, 2022 Issue: Health Issues
  • $20,000 Oct 20, 2022 Issue: Health Issues
  • $20,000 Jul 20, 2022 Issue: Health Issues
  • $20,000 Apr 20, 2022 Issue: Health Issues
  • $20,000 Oct 20, 2021 Issue: Health Issues
  • $20,000 Sep 24, 2021 Issue: Health Issues
  • $20,000 Sep 24, 2021 Issue: Health Issues
U.S. Patents

New patents grants

  • Patent Title: Cancer treatment with combination of plinabulin and taxane Mar. 24, 2020
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of BYSI in WallStreetBets Daily Discussion

BYSI News

Recent insights relating to BYSI

CNBC Recommendations

Recent picks made for BYSI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BYSI

Corporate Flights

Flights by private jets registered to BYSI